Kyverna Therapeutics vs Vertex Pharmaceuticals: 2026 Buy Guide
In 2026, investors face a critical choice between a clinical-stage biotech and a cash-flow powerhouse. This guide com...
Evaluate crypto assets based on use case, supply dynamics, and market liquidity to guide beginner-friendly buying decisions for 2024.
26,888 articlesIn 2026, investors face a critical choice between a clinical-stage biotech and a cash-flow powerhouse. This guide com...
Tellor is upgrading the Palmito testnet to v6.1.4 on March 23, 2026, introducing TokenBridge V2 to harden cross-chain...
Bitcoin steadies near $62,000 as a major bitcoin demand drop sparks debate about whether the market is close to a cyc...
Strategy widens its ATM funding to over $60B to buy BTC, signaling bigger bets on the digital asset. The move could l...
When a pop moment turns personal, fans feel the emotion—and the money questions that follow. This piece translates th...
MemeCore completed its second-stage upgrade, slashing gas fees and enabling smoother on-chain activity. The move spar...
Sellers are reasserting control as Ethereum’s relief rally fades, keeping prices range-bound near critical levels and...
Bitcoin holds near $70,000 as macro pressures and tight liquidity push price into a narrow range ahead of a potential...
A new funding framework could let Ethereum validators redirect up to 10% of staking rewards to ecosystem projects, bu...
A bipartisan group of lawmakers introduced a second bill this week to curb insider trading in prediction markets, exp...
June data show a surge in miner deposits to Binance, with inflows eclipsing 150,000 BTC and marking a four-month peak...
Base, the Coinbase-backed Ethereum Layer 2, is shifting from optimistic rollups to a zero-knowledge-based finality sy...